High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.

@article{Pearson2008HighdoseRA,
  title={High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.},
  author={Andrew D. J. Pearson and Charles Ross Pinkerton and Ian J. Lewis and J. D. Imeson and Caroline Ellershaw and David Machin},
  journal={The Lancet. Oncology},
  year={2008},
  volume={9 3},
  pages={247-56}
}
BACKGROUND The current standard treatment for patients with high-risk neuroblastoma includes initial induction chemotherapy with a 21-day interval between induction treatments. We aimed to assess whether an intensive chemotherapy protocol that had a 10-day interval between treatments would improve event-free survival (EFS) in patients aged 1 year or over with high-risk neuroblastoma. METHODS Between Oct 30, 1990, and March 18, 1999, patients with stage 4 neuroblastoma who had not received… CONTINUE READING
97 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 97 extracted citations

Similar Papers

Loading similar papers…